Crohn disease: effect on children's lifestyles

Wendy Lowe1, Diane Kenwright, John Wyeth

  • 1University of Otago, Wellington, New Zealand.

Insights

Pediatric Crohn disease (CD) impacts quality of life. Longer disease duration correlated with better quality of life, while higher disease activity correlated with poorer quality of life in Wellington children.

Area of Science:

  • Pediatric Gastroenterology
  • Quality of Life Research
  • Health Services Research

Background:

  • Crohn disease (CD) significantly impacts pediatric patients' physical, social, and psychological well-being.
  • Assessing health-related quality of life (HRQoL) is crucial for resource allocation and intervention effectiveness in pediatric CD management.

Purpose of the Study:

  • To investigate the health-related quality of life (HRQoL) in pediatric patients diagnosed with Crohn disease (CD) within the Wellington region.
  • To establish baseline data for future research on HRQoL in young CD patients in New Zealand.

Main Methods:

  • A cohort of 16 pediatric patients (ages 9-18) with Crohn disease (CD) in the Wellington region participated.
  • The IMPACT-III inflammatory bowel disease-specific questionnaire was utilized for assessment, with some participants undergoing cognitive debriefing for cross-cultural adaptation.

Main Results:

  • The mean total HRQoL score was 119.2 (SD 30.7) out of a maximum of 175.
  • A significant positive correlation was found between disease duration and HRQoL (ρ=0.534, p<0.05).
  • A significant negative correlation was observed between disease activity and HRQoL (ρ=-0.596, p<0.05), with patients reporting challenges with treatments and social isolation.

Conclusions:

  • Pediatric patients with Crohn disease (CD) in Wellington may benefit from tailored social and psychological support.
  • This study provides essential baseline HRQoL data for pediatric CD patients in New Zealand, informing future research and clinical practice.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...